tiprankstipranks
Company Announcements

Wai Chun Bio-Technology Faces Board Diversity Challenge

Story Highlights
  • Wai Chun Bio-Technology must address a board diversity issue due to a recent resignation.
  • The company plans to appoint a female director within three months to ensure compliance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Wai Chun Bio-Technology Faces Board Diversity Challenge

Discover the Best Stocks and Maximize Your Portfolio:

Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an update.

Wai Chun Bio-Technology Limited has announced a board diversity issue following the resignation of a female independent non-executive director. This has resulted in a single-gender board, which is not compliant with Hong Kong Stock Exchange’s diversity rules. The company plans to appoint a female director within three months to meet diversity requirements, considering various factors such as gender, age, and professional experience.

More about Wai Chun Bio-Technology Ltd.

YTD Price Performance: 127.14%

Average Trading Volume: 194,025

Technical Sentiment Consensus Rating: Hold

Current Market Cap: HK$19.03M

Learn more about 0660 stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1